Mankato Company and U of M Develop PRRS Vaccine
MINNESOTA - A Mankato-based company, along with researchers from the University of Minnesota, has developed a new pig vaccine that farmers and veterinarians are hoping will gradually obliterate PRRS, a disease that costs the industry more than $550 million a year.